Search SAMHSA Publications and Digital Products
Store Facets Summary
- Clear all filters
- Remove Professional Care Providers
- Remove Public Health Professionals
- Remove Family & Advocates
- Remove Guidelines or Manual
- Remove Advisory
- Remove Suicide
- Remove Opioid Use Disorder
- Remove Depression
- Remove English
- Remove People with Substance Use or Abuse Problems as Population Group
- Remove Practitioner/Professional
Main page content
Published: August 2021The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.
Published: July 2021This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. This is a revision.
Published: November 2015This manual assists clinicians with implementing technology-assisted care. It highlights the importance of using technology-based assessments and interventions in behavioral health treatment services. The manual also discusses how technology reduces barriers to accessing care.
Addressing Suicidal Thoughts and Behaviors in Substance Abuse Treatment: Quick Guide for Clinicians Based on TIP 50
Published: November 2013This quick guide helps clinicians and other service providers address suicide and suicide prevention in patients living with substance use disorders. It covers risk factors and warning signs for suicide, core competencies, and information for administrators and clinical supervisors.